Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 917-925

  Chang, Chih Hsien ^a,b   Wang, Hsin Ell ^a   Wu, Shi Yuan ^a   Fan, Kuo Hsien ^b   Tsai, Tung Hu ^a   Lee, Te Wei ^b   Chang, Shiang Rong ^b   Liu, Ren Shyan ^c   Chen, Chieh Fu ^a   Chen, Chin Hsiung ^b   Fu, Ying Kai ^b,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF NUCLEAR ENERGY RESEARCH   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

Author keywords

Autoradiography; FDG; FET; LLC1 lung carcinoma; MicroPET; Turpentine

Indexed keywords

FLUORODEOXYGLUCOSE F 18; O 2 FLUOROETHYL LEVO TYROSINE F 18; RADIOPHARMACEUTICAL AGENT; TURPENTINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG HALF LIFE; DRUG SYNTHESIS; DRUG UPTAKE; INFLAMMATION; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; WHOLE BODY AUTORADIOGRAPHY;

ANIMALS; AUTORADIOGRAPHY; CARCINOMA, LEWIS LUNG; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; PNEUMONIA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TURPENTINE; TYROSINE;

EID: 33645799975     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Dominioni L, Strauss GM, Imperatori A, Rovera F and Dionigi G: Screening for lung cancer. Chest Surg Clin N Am 10: 729-736, 2000.
3. Avril NE and Weber WA: Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am 43: 189-204, 2005.
4. Halter G, Storck M, Guhlmann A, Frank J, Grosse S and Liewald F: FDG positron emission tomography in the diagnosis of peripheral pulmonary focal lesions. Thorac Cardiovasc Surg 48: 97-101, 2000.
5. Tsuyuguchi N, Sunada I, Ohata K, Takami T, Nishio A, Hara M, Kawabe J, Okamura T and Ochi H: Evaluation of treatment effects in brain abscess with positron emission tomography: comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine. Ann Nucl Med 17: 47-51, 2003.
6. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40: 1367-1373, 1999.
7. Watanabe H, Inoue T, Shinozaki T, Yanagawa T, Ahmed AR, Tomiyoshi K, Oriuchi N, Tokunaga M, Aoki J, Endo K and Takagishi K: PET imaging of musculoskeletal tumours with fluorine-18 alpha-methyltyrosine: comparison with fluorine-18 fluorodeoxyglucose PET. Eur J Nucl Med 27: 1509-1517, 2000.
8. 18)F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes. Eur J Nucl Med Mol Imag 29: 1039-1046, 2002.
9. 18F]fluoropropyl)-L-tyrosine as an oncologic PET tracer. Nucl Med Biol 30: 733-739, 2003.
10. Bakheet SM, Saleem M, Powe J, Al-Amro A, Larsson SG and Mahassin Z: F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection. Clin Nucl Med 25: 273-278, 2000.
11. 18F]FDG as PET probes in a brain tumor-bearing animal model. Nucl Med Biol 32: 367-375, 2005.
12. Luker GD, Sharma V, Pica CM, Dahlheimer JL, Li W, Ochesky J, Ryan CE, Piwnica-Worms H and Piwnica-Worms D: Noninvasive imaging of protein-protein interactions in living animals. Proc Natl Acad Sci USA 99: 6961-6966, 2002.
13. 18F-FDG upatke by microPET and whole-body autoradiography in a fibrosarcoma-bearing mouse model. J Formos Med Assoc 103: 876-881, 2004.
14. 18F-FDG for differentiating tumor from inflammation in a rodent model. J Nucl Med 45: 695-700, 2004.
15. Laverman P, Boerman OC, Corstens FH and Oyen WJ: Fluorinated amino acids for tumour imaging with positron emission tomography. Eur J Nucl Med Mol Imag 29: 681-690, 2002.
16. 11C-methionine for the detection of hilar and mediastinal lymph node metastasis in lung cancer. J Nucl Med 41: 283-290, 2000.
17. Hung GU, Shiau YC, Tsai SC, Ho YJ, Kao CH and Yen RF: Differentiation of radiographically indeterminate solitary pulmonary nodules. Jpn J Clin Oncol 31: 51-54, 2001.
18. 18F-FDG. J Nucl Med 46: 1522-1530, 2005.
19. Yamada S, Kubota K, Kubota R, Ido T and Tamahashi N: High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36: 1301-1306, 1995.
20. 18F]fluoro-D-glucose by fungal-associated inflammation: the differential uptake ratio for blastomyces-associated lesions is as high as for lymphoma and higher than for turpentine abscesses in experimentally induced lesions in rats. Mol Imag Biol 4: 193-200, 2002.
21. Strauss LG: Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23: 1409-1415, 1996.
22. 125I]iodo-alpha-methyl-tyrosine in a human small-cell lung cancer cell line: comparison with L-1. Nucl Med Commun 22: 87-96, 2001.
23. 123/125I-2- iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT. J Nucl Med 46: 532-539, 2005.
24. Lahoutte T, Mertens J, Caveliers V, Franken PR, Everaert H and Bossuyt A: Comparative biodistribution of iodinated amino acids in rats: selection of the optimal analog for oncologic imaging outside the brain. J Nucl Med 44: 1489-1494, 2003.
25. 18F] fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40: 205-212, 1999.
26. 123)I]Iodo-alpha- methyl-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol 29: 625-631, 2002.
27. 18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imag 30: 519-524, 2003.
28. 18F]fluoroethyl)-L-tyrosine as oncologic PET tracer. Appl Radiat Isot 58: 219-225, 2003.
29. 11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 27: 542-549, 2000.
30. 18F- Fluoroethyl)-L-tyrosine in peripheral tumors: first clinical results. J Nucl Med 46: 411-416, 2005.